Sanofi pledges to keep price hikes below healthcare inflation rate: 4 things to know

(By Mackenzie Bean for Becker’s Hospital Review)

Paris-based Sanofi is the latest drugmaker vowing to limit U.S. drug price hikes, reports Financial Times.

Here are four things to know. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.